European Heart Journal Advance Access published online on November 2, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi624
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 University of Florida, College of Medicine, Division of Cardiovascular Medicine, 1600 SW Archer Road, Gainesville, FL, USA
* To whom correspondence should be addressed.
Editorial
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes
Carl J. Pepine, E-mail: pepincj{at}medicine.ufl.edu
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. M. Cooper-DeHoff, M. A. Pacanowski, and C. J. Pepine Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum. J. Am. Coll. Cardiol., February 3, 2009; 53(5 Suppl): S28 - S34. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Bax, B. De Bruyne, A. K. Gitt, S. Kristensen, C. Linde, D. Poldermans, F. J. Pinto, P. Ponikowski, B. D. Prendergast, E. Abagiti-Rosei, et al. Highlights of the 2006 Scientific Sessions of the European Society of Cardiology: Barcelona, Spain, September 2-5, 2006 J. Am. Coll. Cardiol., December 19, 2006; 48(12): 2564 - 2574. [Full Text] [PDF] |
||||
